![pipeline_hero](/wp-content/uploads/2020/08/pipeline_hero.jpg)
PIPELINE OVERVIEW
We have a robust drug development pipeline at various clinical and preclinical stages.
Tap the sections below to expand or download the full pipeline chart.
![Snipaste_2024-05-03_18-55-35](https://beyondspringpharma.com/wp-content/uploads/2024/05/Snipaste_2024-05-03_18-55-35.jpg)
BeyondSpring Subsidiaries: 1) Dalian Wanchunbulin Pharmaceuticals Ltd., which owns China rights to Plinabulin, and 2) Seed Therapeutics, a target protein degradation company.